(Q26864419)

English

Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening

scientific article

In more languages

Statements

scholarly article

1 reference

1 reference

Europe PubMed Central

Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening (English)

1 reference

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

author name string

Robert A. Smith

1

1 reference

Durado Brooks

2

1 reference

Vilma Cokkinides

3

1 reference

Debbie Saslow

4

1 reference

Otis W. Brawley

5

1 reference

language of work or name

1 reference

publication date

2013

1 reference

1 reference

63

1 reference

2

1 reference

88-105

1 reference

New American Cancer Society process for creating trustworthy cancer screening guidelines.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Cancer screening in the United States, 2012: A review of current American Cancer Society guidelines and current issues in cancer screening

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

American Cancer Society guidelines for breast cancer screening: update 2003.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

American Cancer Society guideline for the early detection of cervical neoplasia and cancer

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

American Cancer Society guideline for the early detection of prostate cancer: update 2010

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

American Cancer Society lung cancer screening guidelines

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Effect of three decades of screening mammography on breast-cancer incidence

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Cancer screening in elderly patients: a framework for individualized decision making

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

A breast cancer prediction model incorporating familial and personal risk factors.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

The benefits and harms of breast cancer screening: an independent review

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Mammographic screening programmes in Europe: organization, coverage and participation

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Communicating the balance sheet in breast cancer screening

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

FIT: A Valuable but Underutilized Screening Test for Colorectal Cancer—It's Time for a Change

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

The cost-effectiveness of screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Trends in colorectal cancer screening with home-based fecal occult blood tests in adults ages 50 to 64 years, 2000-2008.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Organized colorectal cancer screening in integrated health care systems

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Examining stools for colon cancer prevention: what are we really looking for?

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Physicians' colorectal cancer screening discussion and recommendation patterns

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Screening for prostate cancer in U.S. men ACPM position statement on preventive practice

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Mortality results from a randomized prostate-cancer screening trial

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Radical prostatectomy versus observation for localized prostate cancer

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Early Lung Cancer Action Project: overall design and findings from baseline screening.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Reduced lung-cancer mortality with low-dose computed tomographic screening

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Benefits and harms of CT screening for lung cancer: a systematic review

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

The role of CA125 in clinical practice

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Tumor markers for early detection of ovarian cancer

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Biomarkers for screening, diagnosis, and monitoring of ovarian cancer

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Effect of Screening on Ovarian Cancer Mortality

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Priorities among effective clinical preventive services: results of a systematic review and analysis

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Delivery of cancer screening: how important is the preventive health examination?

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

A perspective from countries using organized screening programs

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Organizational factors and the cancer screening process

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

How the Affordable Care Act will strengthen the nation's primary care foundation

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Principles of the patient-centered medical home and preventive services delivery

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Breast cancer screening beliefs, recommendations and practices: primary care physicians in the United States.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Tailored interventions to promote mammography screening: a meta-analytic review

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Association between patient-centered medical home rating and operating cost at federally funded health centers

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Horizon's patient-centered medical home program shows practices need much more than payment changes to transform

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Promoting cancer screening within the patient centered medical home.

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Association of insurance with cancer care utilization and outcomes

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Health care reform and women's insurance coverage for breast and cervical cancer screening

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

The effects of Medicaid coverage--learning from the Oregon experiment

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Prostate Cancer Screening Decisions

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21174

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26864419&oldid=2043334770"